Literature DB >> 6772578

An in vitro model for monitoring bacterial responses to antibiotic agents under simulated in vivo conditions.

T Bergan, I B Carlsen, J E Fuglesang.   

Abstract

A new in vitro model for the study of bacterial responses to antibacterial agents at exponentially varying concentrations, i. e. at given elimination half-life values simulating in vivo conditions, is described. The initial concentrations and elimination rates of the agents, composition of bacterial milieu, and commencing density of the bacterial population may be altered. The principal responses of key gram-negative and gram-positive species to bactericidal and bacteriostatic agents and experimental variation are described.

Mesh:

Substances:

Year:  1980        PMID: 6772578     DOI: 10.1007/bf01644942

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

Review 1.  Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors:  R C Li; M Zhu; J J Schentag
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

Review 2.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.

Authors:  Markus Mueller; Amparo de la Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

3.  Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa.

Authors:  J G Zhi; C H Nightingale; R Quintiliani
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

4.  Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model.

Authors:  I Haller
Journal:  Infection       Date:  1982       Impact factor: 3.553

5.  Antibacterial kinetics of ampicillin against Escherichia coli under simulated in vivo conditions.

Authors:  J E Fuglesang; T Bergan
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

6.  Pharmacokinetic-pharmacodynamic modeling of the antibiotic effect of piperacillin in vitro.

Authors:  A Nolting; T Dalla Costa; K H Rand; H Derendorf
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

7.  Antibacterial activity and kill kinetics of ampicillin/sulbactam (CP-45899) combinations against Escherichia coli and Klebsiella aerogenes.

Authors:  J E Fuglesang; T Bergan
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

8.  Post-antibiotic effect of beta-lactam antibiotics on gram-negative bacteria in relation to morphology, initial killing and MIC.

Authors:  H Hanberger; L E Nilsson; M Nilsson; R Maller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

9.  Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes.

Authors:  J E Fuglesang; T Bergan
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

10.  Inhibitory activity and bactericidal kinetics of mecillinam/ampicillin combinations against Enterobacteriaceae, Pseudomonas and Acinetobacter.

Authors:  J E Fuglesang; T Bergan; T Bielecki; A Naterstad; E Namork
Journal:  Infection       Date:  1981       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.